Rabindra Tirouvanziam, PhD
Emory+Children’s Center for Cystic Fibrosis & Airways Disease Research
Department of Pediatrics, Emory University School of Medicine
Division of Pulmonary, Allergy & Immunology, Cystic Fibrosis and Sleep
Rabindra Tirouvanziam earned his PhD at the Embryology Institute of CNRS and College de France near Paris, France, and also holds an Engineering Degree from France's leading biotechnology school, Agro Paris-Tech. Before joining Emory University, he worked as research scientist and later as Instructor at Stanford University School of Medicine with affiliations in the Departments of Pediatrics, Genetics and Psychiatry and Behavioral Sciences.
Dr. Tirouvanziam's laboratory focuses on mechanisms of innate immunity in humans and their relations to chronic human disease, with emphasis on target identification for the development of novel therapies. Dr. Tirouvanziam has led efforts to redefine the fate of neutrophils in the fatal disease cystic fibrosis (CF) and served as principal scientist on phase 1 and 2 clinical trials in CF and autism. Dr. Tirouvanziam's research has been published in the Proceedings of the National Academy of Sciences, Blood, and the Journal of Allergy and Clinical Immunology, among others.